Discover 3 European Penny Stocks With Market Caps Over €30M

In This Article:

The European market has shown cautious optimism recently, with the pan-European STOXX Europe 600 Index ending slightly higher as investors weigh ongoing U.S. trade policy developments and geopolitical efforts. Despite these broader market dynamics, penny stocks remain an intriguing investment area due to their potential for growth at lower price points. Often representing smaller or newer companies, these stocks can offer significant upside when they are backed by strong financials and solid fundamentals.

Top 10 Penny Stocks In Europe

Name

Share Price

Market Cap

Financial Health Rating

Angler Gaming (NGM:ANGL)

SEK3.92

SEK293.94M

★★★★★★

Netgem (ENXTPA:ALNTG)

€0.958

€32.08M

★★★★★★

Transferator (NGM:TRAN A)

SEK2.50

SEK244.2M

★★★★★★

Hifab Group (OM:HIFA B)

SEK3.68

SEK223.89M

★★★★★★

High (ENXTPA:HCO)

€2.74

€53.82M

★★★★★★

Bredband2 i Skandinavien (OM:BRE2)

SEK2.08

SEK1.99B

★★★★☆☆

I.M.D. International Medical Devices (BIT:IMD)

€1.47

€25.46M

★★★★★☆

Nurminen Logistics Oyj (HLSE:NLG1V)

€1.195

€96.26M

★★★★★☆

Deceuninck (ENXTBR:DECB)

€2.345

€324.54M

★★★★★☆

IMS (WSE:IMS)

PLN3.79

PLN128.46M

★★★★☆☆

Click here to see the full list of 425 stocks from our European Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Altia Consultores

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Altia Consultores, S.A. operates in the information and communication technologies (ICT) sector both in Spain and internationally, with a market cap of €329.46 million.

Operations: The company's revenue is primarily derived from its business lines, with Altia contributing €122.39 million, Noesis €72.98 million, Bilbomatics €57.48 million, Exis €8.98 million, and operations in Chile generating €1.43 million.

Market Cap: €329.46M

Altia Consultores, S.A., with a market cap of €329.46 million, operates in the ICT sector and has demonstrated robust financial health with short-term assets (€93.5M) exceeding both short-term (€62.4M) and long-term liabilities (€11.8M). The company’s earnings have grown significantly by 22.6% annually over the past five years, though recent growth (9.9%) lags behind this average and matches industry performance. Altia's debt is well-covered by cash flow (81%), while interest payments are comfortably managed with EBIT covering them 17.9 times over, indicating strong operational efficiency despite its low return on equity of 19.1%.

BME:ALC Debt to Equity History and Analysis as at Feb 2025
BME:ALC Debt to Equity History and Analysis as at Feb 2025

AGF

Simply Wall St Financial Health Rating: ★★★★★★